CombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results
04 mai 2016 16h05 HE
|
CombiMatrix Corporation
Revenues Increase 28% to $3.0 Million on Record Reproductive Health Genetic Screening Test Volume and Higher Average Revenue per Test Conference Call Begins Today at 4:30 p.m. Eastern Time ...
CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
27 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close...
CombiMatrix Provides Strategic Update
21 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal Translocations
05 avr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss Testing
29 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Closes $8.0 Million Underwritten Public Offering
24 mars 2016 09h59 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix to Present at the ROTH Conference
09 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results
17 févr. 2016 16h05 HE
|
CombiMatrix Corporation
Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-Implantation Genetic Screening Test VolumesConference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif.,...
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
17 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss
11 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...